Clearview Wealth Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-54
Closed -$1.37K 575
2023
Q2
$1.37K Hold
54
﹤0.01% 566
2023
Q1
$1.4K Buy
54
+6
+13% +$161 ﹤0.01% 545
2022
Q4
$1.14K Sell
48
-32
-40% -$863 ﹤0.01% 520
2022
Q3
$2K Sell
80
-127
-61% -$4.46K ﹤0.01% 502
2022
Q2
$7K Buy
207
+24
+13% +$1.02K 0.01% 405
2022
Q1
$13K Buy
183
+15
+9% +$1.08K 0.01% 350
2021
Q4
$15K Buy
168
+1
+0.6% +$120 0.01% 366
2021
Q3
$21K Buy
167
+33
+25% +$4.8K 0.01% 330
2021
Q2
$22K Buy
134
+34
+34% +$5.51K 0.01% 331
2021
Q1
$18K Buy
100
+26
+35% +$6.03K 0.01% 345
2020
Q4
$15K Buy
+74
New +$15K 0.01% 331

Other funds holding TDOC

Clearview Wealth Advisors's TDOC Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 54 shares — an estimated $1.37K sold.

Clearview Wealth Advisors first reported a position in TDOC in Q4 2020 and held it in 11 quarters. The position peaked at $22K in Q2 2021. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 54 Teladoc Health shares in Q3 2023, an estimated $1.37K.
  • Clearview Wealth Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 11 quarters.
  • Clearview Wealth Advisors's Teladoc Health position peaked at $22K in Q2 2021.
  • 436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.